Relay Therapeutics (RLAY) Insider Trading & Ownership $3.66 +0.30 (+8.78%) As of 11:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Relay Therapeutics (NASDAQ:RLAY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.87%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$3.37M Get RLAY Insider Trade Alerts Want to know when executives and insiders are buying or selling Relay Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLAY Insider Buying and Selling by Quarter Relay Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/29/2025Brian AdamsInsiderSell18,276$3.68$67,255.68 7/29/2025Donald A BergstromInsiderSell26,701$3.68$98,259.68 7/29/2025Peter RahmerInsiderSell15,724$3.68$57,864.32 7/29/2025Thomas CatinazzoCFOSell18,380$3.68$67,638.40 7/28/2025Brian AdamsInsiderSell1,637$3.74$6,122.38 7/28/2025Donald A BergstromInsiderSell4,069$3.74$15,218.06 7/28/2025Peter RahmerInsiderSell1,359$3.74$5,082.66 7/28/2025Thomas CatinazzoCFOSell1,701$3.74$6,361.74 7/9/2025Sanjiv PatelCEOSell61,379$3.57$219,123.03 4/30/2025Peter RahmerInsiderSell10,739$3.00$32,217.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/30/2025Thomas CatinazzoCFOSell12,943$3.00$38,829.00 4/28/2025Peter RahmerInsiderSell1,364$3.17$4,323.88 4/28/2025Thomas CatinazzoCFOSell2,690$3.17$8,527.30 4/23/2025Sanjiv PatelCEOSell61,422$2.97$182,423.34 3/27/2025Brian AdamsInsiderSell298$2.84$846.32 3/27/2025Thomas CatinazzoCFOSell4,864$2.84$13,813.76 2/13/2025Sanjiv PatelCEOSell75,324$3.70$278,698.80 2/11/2025Sanjiv PatelCEOSell140,182$3.85$539,700.70 1/30/2025Peter RahmerInsiderSell17,250$4.42$76,245.00 1/30/2025Thomas CatinazzoCFOSell20,791$4.42$91,896.22 1/28/2025Peter RahmerInsiderSell1,673$4.63$7,745.99 1/28/2025Thomas CatinazzoCFOSell36,036$4.63$166,846.68 1/22/2025Sanjiv PatelCEOSell125,000$4.80$600,000.00 1/6/2025Peter RahmerInsiderSell16,576$4.45$73,763.20 1/2/2025Peter RahmerInsiderSell32,156$4.15$133,447.40 12/27/2024Brian AdamsInsiderSell299$4.38$1,309.62 12/27/2024Thomas CatinazzoCFOSell4,865$4.42$21,503.30 12/16/2024Sanjiv PatelCEOSell100,000$5.00$500,000.00 10/28/2024Peter RahmerInsiderSell1,621$6.06$9,823.26 10/28/2024Thomas CatinazzoCFOSell6,802$6.06$41,220.12 (Data available from 1/1/2013 forward) RLAY Insider Trading Activity - Frequently Asked Questions Who is on Relay Therapeutics' Insider Roster? The list of insiders at Relay Therapeutics includes Andy Porter, Brian Adams, Donald A Bergstrom, Mark Murcko, Peter Rahmer, Sanjiv Patel, and Thomas Catinazzo. Learn more on insiders at RLAY. What percentage of Relay Therapeutics stock is owned by insiders? 4.87% of Relay Therapeutics stock is owned by insiders. Learn more on RLAY's insider holdings. Which Relay Therapeutics insiders have been selling company stock? The following insiders have sold RLAY shares in the last 24 months: Brian Adams ($75,534.00), Donald A Bergstrom ($128,854.96), Peter Rahmer ($936,634.53), Sanjiv Patel ($2,652,869.29), and Thomas Catinazzo ($656,303.31). How much insider selling is happening at Relay Therapeutics? Insiders have sold a total of 959,513 Relay Therapeutics shares in the last 24 months for a total of $4,450,196.09 sold. Relay Therapeutics Key ExecutivesMr. Alexis A. Borisy A.M. (Age 52)Co-Founder & Independent Chairman Compensation: $92.5kDr. Sanjiv K. Patel M.A. (Age 50)M.B.A., M.D., MBBS, CEO, President & Director Compensation: $1.08MDr. Mark Murcko Ph.D. (Age 64)Co-Founder & Director Compensation: $60kMr. Thomas Catinazzo (Age 47)Chief Financial Officer Compensation: $663.99k5 recent tradesMr. Brian R. Adams J.D. (Age 50)Chief Legal Officer & Secretary Compensation: $627.72kMr. Peter RahmerChief Corporate Development Officer4 recent tradesDr. Donald A. Bergstrom M.D. (Age 52)Ph.D., President of Research & Development Compensation: $1.37M2 recent tradesMs. Dorothee Kern Ph.D.FounderDr. David Elliot Shaw Ph.D. (Age 73)Founder Mr. Matthew P. Jacobson Ph.D.Founder More Insider Trading Tools from MarketBeat Related Companies CPRX Insider Selling XENE Insider Selling APLS Insider Selling IBRX Insider Selling ARWR Insider Selling TWST Insider Selling AGIO Insider Selling IDYA Insider Selling BEAM Insider Selling VCEL Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:RLAY) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersThe Altcoin That Could be Poised to Benefit Most from Trump’s ReturnWith Trump back in office, the crypto tide is turning fast. Regulation is easing. Momentum is building. And ac...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relay Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RLAY Stock Alerts